Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Renalytix plc (LSE:RENX): What Could Move the Shares as London Investors Track the Next Catalyst

Key HighlightsRenalytix is in focus after reporting twelve-monthRevenueof $3.0 million, expanded physician onboarding and broader integration of its kidney-risk test into US clinical practices. Its KidneyIntelX.dkd product aims to support early risk assessment in diabetic kidney disease, and the company recently reported a new …

Ankur Sharma | 05 November 2026

Bioventix plc (BVXP:LSE): Healthcare Catalyst Puts FTSE AIM All-Share Stock in Focus

The investment case turns on evidence of commercial adoption or clinical progress, alongside funding needs. For smaller healthcare companies, the next measurable milestone often matters more than broad market enthusiasm.

Ankur Sharma | 05 November 2026

EDX Medical Group PLC (EDX:LSE): Healthcare Catalyst Puts FTSE AIM All-Share Stock in Focus

The investment case turns on evidence of commercial adoption or clinical progress, alongside funding needs. For smaller healthcare companies, the next measurable milestone often matters more than broad market enthusiasm.

Ankur Sharma | 05 November 2026

Feedback plc (FDBK:LSE): Healthcare Catalyst Puts FTSE AIM All-Share Stock in Focus

The investment case turns on evidence of commercial adoption or clinical progress, alongside funding needs. For smaller healthcare companies, the next measurable milestone often matters more than broad market enthusiasm.

Ankur Sharma | 05 November 2026

HemoGenyx Pharmaceuticals Plc (HEMO:LSE): Healthcare Catalyst Puts FTSE All-Share Stock in Focus

The investment case turns on evidence of commercial adoption or clinical progress, alongside funding needs. For smaller healthcare companies, the next measurable milestone often matters more than broad market enthusiasm.

Ankur Sharma | 05 November 2026

Hikma Pharmaceuticals PLC (HIK:LSE): Healthcare Catalyst Puts FTSE 100 Stock in Focus

The investment case turns on evidence of commercial adoption or clinical progress, alongside funding needs. For smaller healthcare companies, the next measurable milestone often matters more than broad market enthusiasm.

Ankur Sharma | 05 November 2026

MedPal AI plc (MPAL:LSE): Healthcare Catalyst Puts FTSE AIM All-Share Stock in Focus

The investment case turns on evidence of commercial adoption or clinical progress, alongside funding needs. For smaller healthcare companies, the next measurable milestone often matters more than broad market enthusiasm.

Ankur Sharma | 05 November 2026

Poolbeg Pharma plc (POLB:LSE): Healthcare Catalyst Puts FTSE AIM All-Share Stock in Focus

The investment case turns on evidence of commercial adoption or clinical progress, alongside funding needs. For smaller healthcare companies, the next measurable milestone often matters more than broad market enthusiasm.

Ankur Sharma | 05 November 2026

Abingdon Health Plc (ABDX:LSE): Healthcare Catalyst Puts FTSE AIM All-Share Stock in Focus

The investment case turns on evidence of commercial adoption or clinical progress, alongside funding needs. For smaller healthcare companies, the next measurable milestone often matters more than broad market enthusiasm.

Ankur Sharma | 05 November 2026

ConvaTec Group Plc (LSE:CTEC) Recovers +4.27% — What Is Healing This Global Medical Device and Wound Care Specialist?

Medical technology companies with well-established product franchises in chronic care categories tend to generate consistent, predictable revenues as patients continue using their products over extended periods. Any positive update onRevenuegrowth,Marginexpansion, new product launches, or strategic acquisitions would be a catalyst for LSE:CTEC investors monitoring …

Ankur Sharma | 05 November 2026
Support

Hi! How can we help you today?

Loading…